TScan Therapeutics, Inc.
Biotechnology company · Waltham, Massachusetts, United States · Nasdaq: TCRX
TScan Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker TCRX. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2021.
TScan Therapeutics at a glance
What does TScan Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $100 million sold (2021).
Frequently asked questions about TScan Therapeutics
Where is TScan Therapeutics headquartered?
TScan Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does TScan Therapeutics do?
TScan Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is TScan Therapeutics a public company?
Yes. TScan Therapeutics, Inc. trades on Nasdaq under the ticker TCRX.
When was TScan Therapeutics founded?
The earliest incorporation on record for TScan Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Repligen CorpWaltham, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.